Metaplastic breast carcinoma has to be distinguished in the normally observed higher-quality metaplastic carcinoma and also the exceptional types of metaplastic carcinoma with unsure malignant probable (fibromatous-like and adenosquamous carcinoma). Usually, metaplastic breast carcinomas are malignancies with triple-damaging immune phenotype, but t